GT Biopharma
GTBP
GTBP
32 hedge funds and large institutions have $888K invested in GT Biopharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.01% less ownership
Funds ownership: 0.28% → 0.27% (-0.01%)
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14.7K | |
| 2 | +$12.1K | |
| 3 | +$8.75K | |
| 4 |
HF
HRT Financial
New York
|
+$8K |
| 5 |
Jane Street
New York
|
+$4.95K |
Top Sellers
| 1 | -$36K | |
| 2 | -$12.1K | |
| 3 | -$5.63K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$4.92K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.36K |